In the field of nanomedicine, AI is used to analyze large datasets from clinical trials and biological studies to identify potential nanotherapeutics. Machine learning models can predict how nanoparticles will interact with biological systems, enhancing drug delivery and reducing side effects. Additionally, AI-driven analysis helps in designing targeted drug delivery systems that can deliver therapeutic agents directly to diseased cells.
